Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Operating Leases (2019 - 2025)

OptimizeRx's Operating Leases history spans 7 years, with the latest figure at $507000.0 for Q3 2025.

  • For Q3 2025, Operating Leases rose 16.02% year-over-year to $507000.0; the TTM value through Sep 2025 reached $507000.0, up 16.02%, while the annual FY2024 figure was $209000.0, 43.67% down from the prior year.
  • Operating Leases for Q3 2025 was $507000.0 at OptimizeRx, down from $548000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $548000.0 in Q2 2025 and bottomed at $547.0 in Q1 2024.
  • The 5-year median for Operating Leases is $236726.0 (2021), against an average of $260883.1.
  • The largest annual shift saw Operating Leases crashed 99.56% in 2024 before it surged 56572.76% in 2025.
  • A 5-year view of Operating Leases shows it stood at $236726.0 in 2021, then tumbled by 38.95% to $144532.0 in 2022, then surged by 156.69% to $371000.0 in 2023, then tumbled by 43.67% to $209000.0 in 2024, then surged by 142.58% to $507000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Operating Leases are $507000.0 (Q3 2025), $548000.0 (Q2 2025), and $310000.0 (Q1 2025).